☰

Mayumi Kawabe, Ph.D. - Publications

Affiliations: 
2009 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Rao A, Taylor JL, Chi-Sabins N, Kawabe M, Gooding WE, Storkus WJ. Combination therapy with HSP90 inhibitor 17-DMAG reconditions the tumor microenvironment to improve recruitment of therapeutic T cells. Cancer Research. 72: 3196-206. PMID 22552283 DOI: 10.1158/0008-5472.Can-12-0538  0.81
2012 Rao A, Kawabe M, Storkus WJ. Abstract 4399: Immunostimulatory effects of HSP90 inhibition: Insights from combinational immunotherapies targeting EphA2 Cancer Research. 72: 4399-4399. DOI: 10.1158/1538-7445.Am2012-4399  0.807
2011 Mitamura T, Doi Y, Kawabe M, Lilja H, Motomura M, Oishi Y, Yoshizawa K, Seki J. Inhibitory potency of tacrolimus ointment on skin tumor induction in a mouse model of an initiation-promotion skin tumor. The Journal of Dermatology. 38: 562-70. PMID 21352294 DOI: 10.1111/j.1346-8138.2010.01046.x  0.402
2011 Zhao X, Bose A, Komita H, Taylor JL, Kawabe M, Chi N, Spokas L, Lowe DB, Goldbach C, Alber S, Watkins SC, Butterfield LH, Kalinski P, Kirkwood JM, Storkus WJ. Intratumoral IL-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor-associated stromal antigens. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 805-14. PMID 21189473 DOI: 10.1038/Mt.2010.295  0.746
2011 Rao A, Kawabe M, Storkus WJ. Abstract 1805: Integration of 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) in combinational immunotherapy targeting tumor antigen EphA2 Cancer Research. 71: 1805-1805. DOI: 10.1158/1538-7445.Am2011-1805  0.804
2009 Kawabe M, Mandic M, Taylor JL, Vasquez CA, Wesa AK, Neckers LM, Storkus WJ. Heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin enhances EphA2+ tumor cell recognition by specific CD8+ T cells. Cancer Research. 69: 6995-7003. PMID 19690146 DOI: 10.1158/0008-5472.Can-08-4511  0.806
2009 Komita H, Zhao X, Katakam AK, Kumar P, Kawabe M, Okada H, Braughler JM, Storkus WJ. Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity. Cancer Gene Therapy. 16: 883-91. PMID 19444303 DOI: 10.1038/Cgt.2009.33  0.644
2008 Wesa AK, Herrem CJ, Mandic M, Taylor JL, Vasquez C, Kawabe M, Tatsumi T, Leibowitz MS, Finke JH, Bukowski RM, Bruckheimer E, Kinch MS, Storkus WJ. Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonists. Journal of Immunology (Baltimore, Md. : 1950). 181: 7721-7. PMID 19017961 DOI: 10.4049/Jimmunol.181.11.7721  0.712
2007 Storkus WJ, Herrem C, Kawabe M, Cohen PA, Bukowski RM, Finke JH, Wesa AK. Improving immunotherapy by conditionally enhancing MHC class I presentation of tumor antigen-derived Peptide epitopes. Critical Reviews in Immunology. 27: 485-93. PMID 18197809 DOI: 10.1615/Critrevimmunol.V27.I5.60  0.704
1996 Tamano S, Hagiwara A, Tanaka H, Kawabe M, Sano M, Takahashi S, Shirai T. Histopathological Evaluation of Spontaneous Hepatocellular Tumors in B6C3F1 Hybrid Mice. Journal of Toxicologic Pathology. 9: 263-271. DOI: 10.1293/tox.9.263  0.345
Show low-probability matches.